The first thought is that this could have all kinds of good applications as the Bloomberg Report mentions. However, there is a flip side. If the pharmaceutical industry cannot control access to its drugs then just how is Lockheed going to control access to its small drones once they become popular. As with the pharmaceutical industry there is no incentive to limit sales. After all sales are profits.
Is this chapter one to the flip side of potential abuses of these drones? Spy Drone Buzzes Journalist’s Secluded Home